Immunoassays for the measurement of IGF-II, IGFBP-2 and-3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport Values in selected population of athletes

被引:12
作者
Abellan, Rosario [3 ,4 ]
Ventura, Rosa [3 ,4 ]
Palmi, Ilaria [1 ]
di Carlo, Simonetta [1 ]
Bacosi, Antonella [1 ]
Bellver, Montse [2 ]
Olive, Ramon [2 ]
Antonio Pascual, Jose [3 ,4 ]
Pacifici, Roberta [1 ]
Segura, Jordi [3 ,4 ]
Zuccaro, Piergiorgio [1 ]
Pichini, Simona [1 ]
机构
[1] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy
[2] Ctr Alt Rendiment, Barcelona 08190, Spain
[3] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain
[4] Hosp Mar, Inst Municipal Invest Med, Neuropsychopharmacol Program, Bioanal & Analyt Serv Res Grp, Barcelona 08003, Spain
关键词
Growth hormone; Indirect biomarkers; Doping; Validation; Immunoassay; Athletes;
D O I
10.1016/j.jpba.2008.05.037
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
Insulin-like growth factor-II (IGF-II), insulin-like growth factor binding proteins (IGFBPs) -2 and -3 and C-terminal telopeptide of type 1 collagen (ICTP) have been proposed, among others, as indirect biomarkers of the recombinant human growth hormone misuse in sport. An extended intra- and inter-laboratory validation of commercially available immunoassays for biomarkers detection was performed. ELISA assays for total IGF-II, IGFBP-2 and IGFBP-3 (IGF-II/ELISA1: DSLabs, IGFBP-2/ELISA2: Biosource, and IGFBP-3/ELISA3: BioSource) and an EIA assay for ICTP (ICrP/EIA: Orion Diagnostica) were evaluated. The inter- and intro-laboratory precision values were acceptable for all evaluated assays (maximum imprecision of 30% and 66% were found only for the lowest quality control samples of IGF-II and IGFBP-3). Correct accuracy was obtained for all inter-laboratory immunoassays and for IGFBP-2 intro-laboratory immunoassay. The range of concentrations found in serum samples under investigation was always covered by the calibration curves of the studied immunoassays. However, 11% and 15% of the samples felt below the estimated LOQ for IGF-II and ICCP, respectively, in the zone where lower precision was obtained. Although the majority of evaluated assays showed an overall reliability not always suitable for antidoping control analysis, relatively high concordances between laboratory results were obtained for all assays. Evaluated immunoassays were used to measure serum concentrations of IGF-II, IGFBP-2 and -3 and ICTP in elite athletes of various sport disciplines at different moments of the training season; in recreational athletes at baseline conditions and finally in sedentary individuals. Serum IGF-II was statistically higher both in recreational and elite athletes compared to sedentary individuals. Elite athletes showed lower IGFBP-2 and higher IGFBP-3 concentration with respect to recreational athletes and sedentary people. Among elite athletes, serum IGFBP-3 (synchronized swimming), and ICTP (rhythmic gymnastics) concentrations were sport-dependent. Over the training season, within athlete variability was observed for IGFBP-2 in case of taekwondo and IGFBP-2 and -3 in case of weightlifting. Variations due to those aspects should be taken in careful consideration in the hypothesis of setting reference concentration ranges for doping detection. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:844 / 852
页数:9
相关论文
共 19 条
[1]
Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: Insulin-like growth factor I and procollagen type III peptide [J].
Abellan, R. ;
Ventura, R. ;
Pichini, S. ;
Di Giovannandrea, R. ;
Bellver, M. ;
Olive, R. ;
Pacifici, R. ;
Pascual, J. A. ;
Zuccaro, P. ;
Segura, J. .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2006, 27 (12) :976-983
[2]
Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport [J].
Abellan, R ;
Ventura, R ;
Pichini, S ;
Pascual, JA ;
Pacifici, R ;
Di Carlo, S ;
Bacosi, A ;
Segura, J ;
Zuccaro, P .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (01) :75-85
[3]
MEASUREMENT IN MEDICINE - THE ANALYSIS OF METHOD COMPARISON STUDIES [J].
ALTMAN, DG ;
BLAND, JM .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 1983, 32 (03) :307-317
[4]
BAXTER RC, 1989, J BIOL CHEM, V264, P11843
[5]
INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - PEPTIDE, MESSENGER RIBONUCLEIC-ACID AND GENE STRUCTURES, SERUM, AND TISSUE CONCENTRATIONS [J].
DAUGHADAY, WH ;
ROTWEIN, P .
ENDOCRINE REVIEWS, 1989, 10 (01) :68-91
[6]
The growth hormone/insulin-like growth factor-1 axis hormones and bone markers in elite athletes in response to a maximum exercise test [J].
Ehrnborg, C ;
Lange, KHW ;
Dall, R ;
Christiansen, JS ;
Lundberg, PA ;
Baxter, RC ;
Boroujerdi, MA ;
Bengtsson, BA ;
Healey, ML ;
Pentecost, C ;
Longobardi, S ;
Napoli, R ;
Rosén, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :394-401
[7]
Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets [J].
Erotokritou-Mulligan, Ioulietta ;
Bassett, E. Eryl ;
Kniess, Astrid ;
Sonksen, Peter H. ;
Holt, Richard I. G. .
GROWTH HORMONE & IGF RESEARCH, 2007, 17 (05) :416-423
[8]
Fleiss J., 1986, Reliability of measurement: the design and analysis of clinical experiments
[9]
Potential parameters for the detection of hGH doping [J].
Kniess, A ;
Ziegler, E ;
Kratzsch, J ;
Thieme, D ;
Müller, RK .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2003, 376 (05) :696-700
[10]
Chanages of bone turnover markers after marathon running over 245 km [J].
Mouzopoulos, G. ;
Stamatakos, M. ;
Tzurbakis, M. ;
Tsernbeli, A. ;
Manti, C. ;
Safioleas, M. ;
Skandalakis, P. .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2007, 28 (07) :576-579